Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

EEstrella Immunopharma, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
E

Estrella Immunopharma, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

Insider transactions

Insider sentiment

No buy/sell activity
DateNameTitleSharesValueTransactionSource
Aug 25, 2026Liu ChengCEO100,000Incentive Stock Option$74KOption exercise
Aug 25, 2026Liu ChengCEO100,000Common Stock, par value $0.0001 per share$74KExercise / conversion
Aug 18, 2026Xu JiandongChief Financial Officer100,000Incentive Share Option$72KOption exercise
Aug 18, 2026Xu JiandongChief Financial Officer100,000Common Stock, par value $0.0001 per share$72KExercise / conversion
Oct 7, 2025Xu JiandongChief Financial Officer1,000Common Stock, par value $0.0001 per share$1.3KBuy
Sep 22, 2025Xu JiandongChief Financial Officer1,000Common Stock, par value $0.0001 per share$1.1KBuy
Sep 11, 2025Xu JiandongChief Financial Officer100Common Stock, par value $0.0001 per share$105.00Buy
Oct 30, 2024Xu JiandongChief Financial Officer509,204Nonstatutory Share Option$458.3KGrant / award
Oct 30, 2024Xu JiandongChief Financial Officer490,796Incentive Share Option$441.7KGrant / award
Oct 30, 2024Liu ChengChief Executive Officer509,204Nonstatutory Share Option$458.3KGrant / award
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • Insider Transactions
$0.49Close ยท Sep 22, 2026